ROCHE I (RO.SW) Financials
RO.SW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 90.5 billion | 57.2 billion |
| 2023-06-30 | 84.4 billion | 54.0 billion |
| 2023-03-31 | 84.4 billion | 54.0 billion |
| 2022-12-31 | 88.2 billion | 56.1 billion |
RO.SW Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 5.2 billion | 447.0 million |
| 2023-06-30 | 3.1 billion | 191.5 million |
| 2023-03-31 | 3.1 billion | 191.5 million |
| 2022-12-31 | 6.1 billion | 403.0 million |
RO.SW Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 4.4 billion |
| 2023-06-30 | 3.6 billion |
| 2023-03-31 | 3.6 billion |
| 2022-12-31 | 3.9 billion |
RO.SW Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 10.5 billion | - | 1.6 billion |
| 2023-06-30 | 7.5 billion | 20.3 billion | - |
| 2023-03-31 | 7.5 billion | - | - |
| 2022-12-31 | 9.8 billion | 21.4 billion | 1.2 billion |
RO.SW Shares Outstanding
RO.SW Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.7 billion | 6.9 billion | - | - |
| 2023-06-30 | 870.0 million | 6.3 billion | 6.5 billion | - |
| 2023-03-31 | 870.0 million | 3.5 billion | - | - |
| 2022-12-31 | 2.5 billion | 7.4 billion | 643.5 million | 2.6 billion |
RO.SW Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 28.9 billion | 8.3 billion |
| 2023-06-30 | 29.8 billion | 7.5 billion |
| 2023-03-31 | 15.3 billion | 3.8 billion |
| 2022-12-31 | 31.0 billion | 9.1 billion |
RO.SW
Price: CHF235.60
Dividend Yield: 0.04%
Forward Dividend Yield: 4.07%
Payout Ratio: 67.13%
Dividend Per Share: 9.60 CHF
Earnings Per Share: 14.30 CHF
P/E Ratio: 18.12
Exchange: EBS
Sector: Healthcare
Industry: Drug Manufacturers - General
Volume: 17105
Market Capitalization: 180.2 billion
Average Dividend Frequency: 1
Years Paying Dividends: 30
DGR3: 1.82%
DGR5: 2.75%
DGR10: 2.61%
DGR20: 14.71%